BRIEF-PDS Biotech Announces Scheduling Of Type C Meeting With U.S. Food And Drug Administration

Reuters12-02

Dec 2 (Reuters) - PDS Biotechnology Corp PDSB.O:

PDS BIOTECH ANNOUNCES SCHEDULING OF TYPE C MEETING WITH U.S. FOOD AND DRUG ADMINISTRATION (“FDA”)
PDS BIOTECHNOLOGY CORP - MEETING TO DISCUSS ACCELERATED APPROVAL FOR PDS0101

Source text: ID:nGNX1kMJ0

Further company coverage: PDSB.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2588055796?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 21:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588055796","market":"fut","top_or_hot":-1,"title":"BRIEF-PDS Biotech Announces Scheduling Of Type C Meeting With U.S. Food And Drug Administration","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-PDS Biotech Announces Scheduling Of Type C Meeting With U.S. Food And Drug Administration</title></head><body><p><span>Dec 2 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/PDSB\">PDS Biotechnology</a> Corp <span>PDSB.O</span>:</p><ul><li><p>PDS BIOTECH ANNOUNCES SCHEDULING OF TYPE C MEETING WITH U.S. FOOD AND DRUG ADMINISTRATION (“FDA”)</p></li><li><p>PDS BIOTECHNOLOGY CORP - MEETING TO DISCUSS ACCELERATED APPROVAL FOR PDS0101</p></li></ul><p>Source text: <span>ID:nGNX1kMJ0</span></p><p>Further company coverage: <span>PDSB.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-PDS Biotech Announces Scheduling Of Type C Meeting With U.S. Food And Drug Administration</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-PDS Biotech Announces Scheduling Of Type C Meeting With U.S. Food And Drug Administration\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-02 21:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-PDS Biotech Announces Scheduling Of Type C Meeting With U.S. Food And Drug Administration</title></head><body><p><span>Dec 2 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/PDSB\">PDS Biotechnology</a> Corp <span>PDSB.O</span>:</p><ul><li><p>PDS BIOTECH ANNOUNCES SCHEDULING OF TYPE C MEETING WITH U.S. FOOD AND DRUG ADMINISTRATION (“FDA”)</p></li><li><p>PDS BIOTECHNOLOGY CORP - MEETING TO DISCUSS ACCELERATED APPROVAL FOR PDS0101</p></li></ul><p>Source text: <span>ID:nGNX1kMJ0</span></p><p>Further company coverage: <span>PDSB.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PDSB","symbol_name":"PDS Biotechnology Corporation","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUABR8LGB:1","article_id":"2588055796","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2588055796","pubTimestamp":1764682496,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-PDS Biotech Announces Scheduling Of Type C Meeting With U.S. Food And Drug AdministrationDec 2 (Reuters) - PDS Biotechnology Corp PDSB.O:PDS BIOTECH ANNOUNCES SCHEDULING OF TYPE C MEETING WITH U","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PDSB":"PDS Biotechnology Corporation","BK4139":"生物科技"},"translate_title":"简介-PDS Biotech宣布安排与美国食品和药物管理局举行C型会议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PDSB":0.9},"content_text":"BRIEF-PDS Biotech Announces Scheduling Of Type C Meeting With U.S. Food And Drug AdministrationDec 2 (Reuters) - PDS Biotechnology Corp PDSB.O:PDS BIOTECH ANNOUNCES SCHEDULING OF TYPE C MEETING WITH U.S. FOOD AND DRUG ADMINISTRATION (“FDA”)PDS BIOTECHNOLOGY CORP - MEETING TO DISCUSS ACCELERATED APPROVAL FOR PDS0101Source text: ID:nGNX1kMJ0Further company coverage: PDSB.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2588055796","isCrawlerRequest":true}